Applied UV Inc

Applied UV Inc

AUVI - Insider Information

Get informed when a big investor buys or sells

+ Follow
Market Cap$37
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Applied UV IncApplied UV Inc0--59%-0.6

Insider Trades

Loading insider trades…

Congress Trades

Loading congress trades…

Share Statistics

Market cap$37.00
Enterprise Value$13.45 Million
Earnings per Share$-35.63
Beta-1.1
Outstanding Shares370,571

Return

Return on Equity-58.70%ROE
Return on Assets-25.02%
Return on Invested Capital-42.06%

Valuation & Multiples

P/E Ratio0P/E Ratio
PEG0PEG
Price to Sales0.0Price to Sales
Price to Book Ratio0.0Price to Book Ratio
Enterprise Value to Revenue0.33
Enterprise Value to EBIT-1.05
Enterprise Value to Net Income-1
Total Debt to Enterprise1.08
Debt to Equity0.59Debt to Equity

Revenue Sources

No data

Last Earnings Call

Report Date
August 31, 2026
EPS Estimate
-
Consensus analyst estimate
Revenue Estimate
-
Consensus analyst estimate

Next Earnings Call

Expected Date
November 16, 2026
EPS Estimate
$-17.50
Consensus analyst estimate
Revenue Estimate
$1.15 M
Consensus analyst estimate

Institutional Sentiment (Put/Call)

No data available for the latest quarter.

Institutional Ownership

No data available for the latest quarter.

About Applied UV Inc

37 employees

Applied UV is focused on the development and acquisition of technology that addresses infection prevention in the healthcare, hospitality, commercial and residential markets. Our products utilize disinfection technology that applies the ...

Applied UV Insider Information FAQ

In the latest 13F quarter on Stockcircle, 1 top investor reduced or sold among tracked top investors. Changes are based on reported share counts in their quarterly filings, not day-to-day trading.

Form 4 insider trades are added as new filings are imported. Top investor 13F holdings refresh after each quarterly filing cycle. Politician trade disclosures are added when new reports are published on Stockcircle.